CHF JOINS EUROPEAN STUDY TO DEVELOP NEW HEART ‘MINI’ DRUG FOR CHILDREN
CHF have joined a five-year study funded by the EU Commission to develop a child friendly form of an existing drug that will allow treating children of all ages with heart problems. The LENA study will trial the drug, Enalapril (ACE inhibitor) in the new form of mini-tablets, which are less than 3mm and quickly dissolve in the mouth, allowing for the correct dosage to be administered.
This study marks a first step in developing medicines in the form of mini-tablets for children, which will ultimately help tailor drug treatment to the specific needs of young patients.
The trial will be running in seven countries and CHF are keen to hear from parents/carers with children up to age 18, who are currently on Enalapril with a heart condition (dilated cardiomyopathy and/or left ventricular dysfunction (LVD)) and would like to take part in the trial.